Sheffield-based biotech business, Benchmark Holdings, has appointed Septima Maguire as its new Chief Finance Officer.
Beginning her new role in November, Ms Maguire, takes over from Mark Plampin who will remain with the business until January 2020 to ensure an effective transaction.
Ms Maguire joins from Dechra Pharmaceuticals, the FTSE 250 international provider of specialist veterinary pharmaceuticals and related products, where she spent four years.
Having joined as Group Financial Controller she was Acting Group Finance Director between 2016 and 2017.
She was most recently Corporate Development Director overseeing all aspects of acquisition activities, strategic projects, business development and investment initiatives playing a significant role in supporting the company during a period of high growth.
Previously, she held several senior finance roles at Ardagh Group, the international packaging manufacturer with revenues of €9.1 billion, over a period of six years.
“We are delighted to have recruited someone of Septima’s calibre,” said Benchmark CEO Malcom Pye.
He added: “She will be a valuable member of the leadership team as we focus on implementing structural and operational efficiencies and delivering on our five year strategy to drive future growth and profitability.”